{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:32:54Z","timestamp":1782513174936,"version":"3.54.5"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00702-024-02793-z","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T10:01:55Z","timestamp":1718359315000},"page":"971-986","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effects of association between resveratrol and ketamine on behavioral and biochemical analysis in mice"],"prefix":"10.1007","volume":"131","author":[{"given":"Patr\u00edcia Zorzi","family":"Juliani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talita","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getulio Nicola","family":"Bressan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Camponogara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Marchesan","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e1lia","family":"Brucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5517-0144","authenticated-orcid":false,"given":"Roselei","family":"Fachinetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,14]]},"reference":[{"key":"2793_CR1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/J.EJPHAR.2018.04.008","volume":"829","author":"SF Ahmad","year":"2018","unstructured":"Ahmad SF, Ansari MA, Nadeem A et al (2018) Resveratrol attenuates pro-inflammatory cytokines and activation of JAK1-STAT3 in BTBR T\u2009+\u2009Itpr3tf\/J autistic mice. Eur J Pharmacol 829:70\u201378. https:\/\/doi.org\/10.1016\/J.EJPHAR.2018.04.008","journal-title":"Eur J Pharmacol"},{"key":"2793_CR2","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/J.BBADIS.2014.09.011","volume":"1852","author":"S Bastianetto","year":"2015","unstructured":"Bastianetto S, M\u00e9nard C, Quirion R (2015) Neuroprotective action of resveratrol. Biochim Biophys Acta 1852:1195\u20131201. https:\/\/doi.org\/10.1016\/J.BBADIS.2014.09.011","journal-title":"Biochim Biophys Acta"},{"key":"2793_CR4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/J.BRAINRESBULL.2018.03.006","volume":"139","author":"B Ben-Azu","year":"2018","unstructured":"Ben-Azu B, Aderibigbe AO, Ajayi AM et al (2018) Involvement of GABAergic, BDNF and Nox-2 mechanisms in the prevention and reversal of ketamine-induced schizophrenia-like behavior by morin in mice. Brain Res Bull 139:292\u2013306. https:\/\/doi.org\/10.1016\/J.BRAINRESBULL.2018.03.006","journal-title":"Brain Res Bull"},{"key":"2793_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/S11011-022-01075-5","volume":"37","author":"B Ben-Azu","year":"2022","unstructured":"Ben-Azu B, Adebayo OG, Jarikre TA et al (2022) Taurine, an essential \u03b2-amino acid insulates against ketamine-induced experimental psychosis by enhancement of cholinergic neurotransmission, inhibition of oxidative\/nitrergic imbalances, and suppression of COX-2\/iNOS immunoreactions in mice. Metabolic Brain Disease 2022 37:8. https:\/\/doi.org\/10.1007\/S11011-022-01075-5","journal-title":"Metabolic Brain Disease 2022"},{"key":"2793_CR5","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/S11064-022-03808-5\/METRICS","volume":"48","author":"B Ben-Azu","year":"2023","unstructured":"Ben-Azu B, Uruaka CI, Ajayi AM et al (2023a) Reversal and preventive pleiotropic mechanisms involved in the antipsychotic-like Effect of Taurine, an essential \u03b2-Amino acid in ketamine-Induced Experimental Schizophrenia in mice. Neurochem Res 48:816\u2013829. https:\/\/doi.org\/10.1007\/S11064-022-03808-5\/METRICS","journal-title":"Neurochem Res"},{"key":"2793_CR6","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/S11064-022-03808-5\/FIGURES\/7","volume":"48","author":"B Ben-Azu","year":"2023","unstructured":"Ben-Azu B, Uruaka CI, Ajayi AM et al (2023b) Reversal and preventive pleiotropic mechanisms involved in the antipsychotic-like Effect of Taurine, an essential \u03b2-Amino acid in ketamine-Induced Experimental Schizophrenia in mice. Neurochem Res 48:816\u2013829. https:\/\/doi.org\/10.1007\/S11064-022-03808-5\/FIGURES\/7","journal-title":"Neurochem Res"},{"key":"2793_CR7","doi-asserted-by":"publisher","first-page":"306005","DOI":"10.3389\/FPSYT.2017.00221\/BIBTEX","volume":"8","author":"MM Borovcanin","year":"2017","unstructured":"Borovcanin MM, Jovanovic I, Radosavljevic G et al (2017) Interleukin-6 in schizophrenia-Is there a therapeutic relevance? Front Psychiatry 8:306005. https:\/\/doi.org\/10.3389\/FPSYT.2017.00221\/BIBTEX","journal-title":"Front Psychiatry"},{"key":"2793_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/fbp.0b013e328341e9b4","volume":"22","author":"A Busanello","year":"2011","unstructured":"Busanello A, Barbosa NBV, Peroza LR et al (2011) Resveratrol protects against a model of vacuous chewing movements induced by reserpine in mice. Behav Pharmacol 22:71\u201375. https:\/\/doi.org\/10.1097\/fbp.0b013e328341e9b4","journal-title":"Behav Pharmacol"},{"key":"2793_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/J.PBB.2012.01.007","volume":"101","author":"A Busanello","year":"2012","unstructured":"Busanello A, Peroza LR, Wagner C et al (2012) Resveratrol reduces vacuous chewing movements induced by acute treatment with fluphenazine. Pharmacol Biochem Behav 101:307\u2013310. https:\/\/doi.org\/10.1016\/J.PBB.2012.01.007","journal-title":"Pharmacol Biochem Behav"},{"key":"2793_CR9","doi-asserted-by":"publisher","unstructured":"Busanello A, Leal CQ, Peroza LR et al (2017) Resveratrol protects against vacuous chewing movements induced by chronic treatment with Fluphenazine. Neurochem Res 42:3033\u20133040. https:\/\/doi.org\/10.1007\/s11064-017-2335-4","DOI":"10.1007\/s11064-017-2335-4"},{"key":"2793_CR11","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/CBIC.201300754","volume":"15","author":"E Calleri","year":"2014","unstructured":"Calleri E, Pochetti G, Dossou KSS et al (2014) Resveratrol and its metabolites bind to PPARs. ChemBioChem 15:1154\u20131160. https:\/\/doi.org\/10.1002\/CBIC.201300754","journal-title":"ChemBioChem"},{"key":"2793_CR12","doi-asserted-by":"publisher","first-page":"7816","DOI":"10.3390\/MOLECULES27227816\/S1","volume":"27","author":"S Carradori","year":"2022","unstructured":"Carradori S, Fantacuzzi M, Ammazzalorso A et al (2022) Resveratrol analogues as dual inhibitors of Monoamine Oxidase B and Carbonic anhydrase VII: a New Multi-target Combination for neurodegenerative diseases? Molecules 27:7816. https:\/\/doi.org\/10.3390\/MOLECULES27227816\/S1","journal-title":"Molecules"},{"key":"2793_CR14","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/J.SCHRES.2016.04.044","volume":"175","author":"APC Ceretta","year":"2016","unstructured":"Ceretta APC, Schaffer LF, de Freitas CM et al (2016) Gabapentin prevents behavioral changes on the amphetamine-induced animal model of schizophrenia. Schizophr Res 175:230\u2013231. https:\/\/doi.org\/10.1016\/J.SCHRES.2016.04.044","journal-title":"Schizophr Res"},{"key":"2793_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/J.PBB.2018.01.003","volume":"166","author":"APC Ceretta","year":"2018","unstructured":"Ceretta APC, de Freitas CM, Schaffer LF et al (2018) Gabapentin reduces haloperidol-induced vacuous chewing movements in mice. Pharmacol Biochem Behav 166:21\u201326. https:\/\/doi.org\/10.1016\/J.PBB.2018.01.003","journal-title":"Pharmacol Biochem Behav"},{"key":"2793_CR15","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1007\/s00702-018-1887-z","volume":"125","author":"M Chamoli","year":"2018","unstructured":"Chamoli M, Chinta SJ, Andersen JK (2018) An inducible MAO-B mouse model of Parkinson\u2019s disease: a tool towards better understanding basic disease mechanisms and developing novel therapeutics. J Neural Transm 125:1651\u20131658. https:\/\/doi.org\/10.1007\/s00702-018-1887-z","journal-title":"J Neural Transm"},{"key":"2793_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5402\/2012\/595141","volume":"2012","author":"M Chatterjee","year":"2012","unstructured":"Chatterjee M, Jaiswal M, Palit G (2012) Comparative evaluation of forced swim test and tail suspension test as models of negative Symptom of Schizophrenia in rodents. ISRN Psychiatry 2012:1\u20135. https:\/\/doi.org\/10.5402\/2012\/595141","journal-title":"ISRN Psychiatry"},{"key":"2793_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/J.SCHRES.2018.02.049","volume":"199","author":"WJ Cheng","year":"2018","unstructured":"Cheng WJ, Chen CH, Chen CK et al (2018) Similar psychotic and cognitive profile between ketamine dependence with persistent psychosis and schizophrenia. Schizophr Res 199:313\u2013318. https:\/\/doi.org\/10.1016\/J.SCHRES.2018.02.049","journal-title":"Schizophr Res"},{"key":"2793_CR18","doi-asserted-by":"publisher","unstructured":"Corpas R, Gri\u00f1\u00e1n-Ferr\u00e9 C, Rodr\u00edguez-Farr\u00e9 E et al (2018) Resveratrol Induces Brain Resilience Against Alzheimer Neurodegeneration Through Proteostasis Enhancement. Molecular Neurobiology 2018 56:2 56:1502\u20131516. https:\/\/doi.org\/10.1007\/S12035-018-1157-Y","DOI":"10.1007\/S12035-018-1157-Y"},{"key":"2793_CR19","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/J.BBAGEN.2016.01.017","volume":"1860","author":"MR De Oliveira","year":"2016","unstructured":"De Oliveira MR, Nabavi SF, Manayi A et al (2016) Resveratrol and the mitochondria: from triggering the intrinsic apoptotic pathway to inducing mitochondrial biogenesis, a mechanistic view. Biochimica et Biophysica Acta (BBA). - Gen Subj 1860:727\u2013745. https:\/\/doi.org\/10.1016\/J.BBAGEN.2016.01.017","journal-title":"- Gen Subj"},{"key":"2793_CR20","doi-asserted-by":"publisher","unstructured":"Denninger JK, Smith BM, Kirby ED (2018) Novel Object Recognition and Object Location Behavioral Testing in Mice on a Budget. JoVE (Journal of Visualized Experiments) 2018:e58593. https:\/\/doi.org\/10.3791\/58593","DOI":"10.3791\/58593"},{"key":"2793_CR21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/J.NEUROPHARM.2011.10.010","volume":"62","author":"V Di Liberto","year":"2012","unstructured":"Di Liberto V, M\u00e4kel\u00e4 J, Korhonen L et al (2012) Involvement of estrogen receptors in the resveratrol-mediated increase in dopamine transporter in human dopaminergic neurons and in striatum of female mice. Neuropharmacology 62:1011\u20131018. https:\/\/doi.org\/10.1016\/J.NEUROPHARM.2011.10.010","journal-title":"Neuropharmacology"},{"key":"2793_CR22","doi-asserted-by":"publisher","unstructured":"Enayati A, Ghojoghnejad M, Roufogalis BD et al (2022) Impact of Phytochemicals on PPAR Receptors: Implications for Disease Treatments. PPAR Res 2022:. https:\/\/doi.org\/10.1155\/2022\/4714914","DOI":"10.1155\/2022\/4714914"},{"key":"2793_CR23","doi-asserted-by":"publisher","unstructured":"Eneni AEO, Ben-Azu B, Ajayi AM, Aderibibge AO (2023) Lipopolysaccharide exacerbates ketamine-Induced psychotic-like Behavior, oxidative stress, and Neuroinflammation in mice: ameliorative effect of Diosmin. J Mol Neurosci 73:129\u2013142. https:\/\/doi.org\/10.1007\/S12031-022-02077-9\/FIGURES\/3","DOI":"10.1007\/S12031-022-02077-9\/FIGURES\/3"},{"key":"2793_CR24","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/J.PNPBP.2007.06.028","volume":"31","author":"R Fachinetto","year":"2007","unstructured":"Fachinetto R, Villarinho JG, Wagner C et al (2007) Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: role of dopamine transporter. Prog Neuropsychopharmacol Biol Psychiatry 31:1478\u20131486. https:\/\/doi.org\/10.1016\/J.PNPBP.2007.06.028","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2793_CR25","doi-asserted-by":"publisher","first-page":"114242","DOI":"10.1016\/J.EJMECH.2022.114242","volume":"233","author":"M Fantacuzzi","year":"2022","unstructured":"Fantacuzzi M, Amoroso R, Carradori S, De Filippis B (2022) Resveratrol-based compounds and neurodegeneration: recent insight in multitarget therapy. Eur J Med Chem 233:114242. https:\/\/doi.org\/10.1016\/J.EJMECH.2022.114242","journal-title":"Eur J Med Chem"},{"key":"2793_CR26","doi-asserted-by":"publisher","first-page":"137436","DOI":"10.1016\/J.NEULET.2023.137436","volume":"813","author":"A Farkhakfar","year":"2023","unstructured":"Farkhakfar A, Hassanpour S, Zendehdel M (2023) Resveratrol plays neuroprotective role on ketamine-induced schizophrenia-like behaviors and oxidative damage in mice. Neurosci Lett 813:137436. https:\/\/doi.org\/10.1016\/J.NEULET.2023.137436","journal-title":"Neurosci Lett"},{"key":"2793_CR27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/S00702-014-1257-4\/TABLES\/2","volume":"122","author":"FH Figueira","year":"2015","unstructured":"Figueira FH, Leal CQ, de Moraes Reis E et al (2015) Effects of diphenyl diselenide on behavioral and biochemical changes induced by amphetamine in mice. J Neural Transm 122:201\u2013209. https:\/\/doi.org\/10.1007\/S00702-014-1257-4\/TABLES\/2","journal-title":"J Neural Transm"},{"key":"2793_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.pharmthera.2014.02.010","volume":"143","author":"JPM Finberg","year":"2014","unstructured":"Finberg JPM (2014) Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release. Pharmacol Ther 143:133\u2013152. https:\/\/doi.org\/10.1016\/j.pharmthera.2014.02.010","journal-title":"Pharmacol Ther"},{"key":"2793_CR29","doi-asserted-by":"publisher","unstructured":"Finberg JPM, Rabey JM (2016) Inhibitors of MAO-A and MAO-B in psychiatry and neurology. Front Pharmacol 7. https:\/\/doi.org\/10.3389\/FPHAR.2016.00340","DOI":"10.3389\/FPHAR.2016.00340"},{"key":"2793_CR30","doi-asserted-by":"crossref","unstructured":"Frohlich J, Van Horn JD (2013) Reviewing the ketamine model for schizophrenia. https:\/\/doi.org\/10.1177\/0269881113512909 28:287\u2013302.","DOI":"10.1177\/0269881113512909"},{"key":"2793_CR31","doi-asserted-by":"publisher","first-page":"109104","DOI":"10.1016\/J.EXER.2022.109104","volume":"220","author":"T Hann Yih","year":"2022","unstructured":"Hann Yih T, Abd Ghapor AA, Agarwal R et al (2022) Effect of trans-resveratrol on glutamate clearance and visual behaviour in rats with glutamate induced retinal injury. Exp Eye Res 220:109104. https:\/\/doi.org\/10.1016\/J.EXER.2022.109104","journal-title":"Exp Eye Res"},{"key":"2793_CR32","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/1028415X.2019.1641995","volume":"24","author":"CP Hsieh","year":"2021","unstructured":"Hsieh CP, Chang WT, Chen L et al (2021) Differential inhibitory effects of resveratrol on excitotoxicity and synaptic plasticity: involvement of NMDA receptor subtypes. Nutr Neurosci 24:443\u2013458. https:\/\/doi.org\/10.1080\/1028415X.2019.1641995","journal-title":"Nutr Neurosci"},{"key":"2793_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/BS.APHA.2020.02.005","volume":"89","author":"SZ Iqbal","year":"2020","unstructured":"Iqbal SZ, Mathew SJ (2020) Ketamine for depression clinical issues. Adv Pharmacol 89:131\u2013162. https:\/\/doi.org\/10.1016\/BS.APHA.2020.02.005","journal-title":"Adv Pharmacol"},{"key":"2793_CR34","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/J.EJPHAR.2008.10.005","volume":"600","author":"F Jin","year":"2008","unstructured":"Jin F, Wu Q, Lu YF et al (2008) Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson\u2019s disease in rats. Eur J Pharmacol 600:78\u201382. https:\/\/doi.org\/10.1016\/J.EJPHAR.2008.10.005","journal-title":"Eur J Pharmacol"},{"key":"2793_CR35","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/J.1476-5381.2011.01386.X","volume":"164","author":"C Jones","year":"2011","unstructured":"Jones C, Watson D, Fone K (2011) Animal models of schizophrenia. Br J Pharmacol 164:1162\u20131194. https:\/\/doi.org\/10.1111\/J.1476-5381.2011.01386.X","journal-title":"Br J Pharmacol"},{"key":"2793_CR37","doi-asserted-by":"publisher","unstructured":"Kalueff AV, Wayne Aldridge J, Laporte JL et al (2007) Analyzing grooming microstructure in neurobehavioral experiments. Nature Protocols 2007 2:10 2:2538\u20132544. https:\/\/doi.org\/10.1038\/nprot.2007.367","DOI":"10.1038\/nprot.2007.367"},{"key":"2793_CR36","doi-asserted-by":"publisher","unstructured":"Kalueff AV, Stewart AM, Song C et al (2015) Neurobiology of rodent self-grooming and its value for translational neuroscience. Nature Reviews Neuroscience 2015 17:1 17:45\u201359. https:\/\/doi.org\/10.1038\/nrn.2015.8","DOI":"10.1038\/nrn.2015.8"},{"key":"2793_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2174\/157015911795017353","volume":"9","author":"K Kanthasamy","year":"2011","unstructured":"Kanthasamy K, Gordon R, Jin H et al (2011) Neuroprotective Effect of Resveratrol Against Methamphetamine-Induced Dopaminergic Apoptotic Cell Death in a Cell Culture Model of Neurotoxicity. Curr Neuropharmacol 9:49\u201353. https:\/\/doi.org\/10.2174\/157015911795017353","journal-title":"Curr Neuropharmacol"},{"key":"2793_CR39","doi-asserted-by":"publisher","unstructured":"Kokkinou M, Ashok AH, Howes OD (2017) The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders. Molecular Psychiatry 2018 23:1 23:59\u201369. https:\/\/doi.org\/10.1038\/mp.2017.190","DOI":"10.1038\/mp.2017.190"},{"key":"2793_CR40","doi-asserted-by":"publisher","first-page":"113293","DOI":"10.1016\/J.JEP.2020.113293","volume":"265","author":"BN Krum","year":"2021","unstructured":"Krum BN, Molz de Freitas C, Chiapinotto Ceretta AP et al (2021) Kava decreases the stereotyped behavior induced by amphetamine in mice. J Ethnopharmacol 265:113293. https:\/\/doi.org\/10.1016\/J.JEP.2020.113293","journal-title":"J Ethnopharmacol"},{"key":"2793_CR41","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/ARCHPSYC.1994.03950030035004","volume":"51","author":"JH Krystal","year":"1994","unstructured":"Krystal JH, Karper LP, Seibyl JP et al (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: Psychotomimetic, Perceptual, Cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199\u2013214. https:\/\/doi.org\/10.1001\/ARCHPSYC.1994.03950030035004","journal-title":"Arch Gen Psychiatry"},{"key":"2793_CR42","doi-asserted-by":"publisher","unstructured":"Li Y, Yu L, Zhao L et al (2017) Resveratrol modulates cocaine-induced inhibitory synaptic plasticity in VTA dopamine neurons by inhibiting phosphodiesterases (PDEs). Scientific Reports 2017 7:1 7:1\u201310. https:\/\/doi.org\/10.1038\/s41598-017-16034-9","DOI":"10.1038\/s41598-017-16034-9"},{"key":"2793_CR43","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.1111\/BPH.13222","volume":"172","author":"D Lodge","year":"2015","unstructured":"Lodge D, Mercier MS (2015) Ketamine and phencyclidine: the good, the bad and the unexpected. Br J Pharmacol 172:4254\u20134276. https:\/\/doi.org\/10.1111\/BPH.13222","journal-title":"Br J Pharmacol"},{"key":"2793_CR44","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"FARRAL LOWRY OH, ROSEBROUGH NJ","year":"1951","unstructured":"LOWRY OH, ROSEBROUGH NJ FARRAL, RANDALL RJ (1951) PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT. J Biol Chem 193:265\u2013275. https:\/\/doi.org\/10.1016\/S0021-9258(19)52451-6","journal-title":"J Biol Chem"},{"key":"2793_CR45","doi-asserted-by":"publisher","first-page":"13824","DOI":"10.3390\/IJMS232213824","volume":"23","author":"M \u013dupt\u00e1k","year":"2022","unstructured":"\u013dupt\u00e1k M, Fi\u0161ar Z, Hroudov\u00e1 J (2022) Agomelatine, ketamine and Vortioxetine Attenuate Energy Cell Metabolism\u2014In Vitro Study. Int J Mol Sci 2022 23:13824. https:\/\/doi.org\/10.3390\/IJMS232213824","journal-title":"Int J Mol Sci 2022"},{"key":"2793_CR46","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/S11011-016-9927-6\/FIGURES\/3","volume":"32","author":"MG Magaji","year":"2017","unstructured":"Magaji MG, Iniaghe LO, Abolarin M et al (2017) Neurobehavioural evaluation of resveratrol in murine models of anxiety and schizophrenia. Metab Brain Dis 32:437\u2013442. https:\/\/doi.org\/10.1007\/S11011-016-9927-6\/FIGURES\/3","journal-title":"Metab Brain Dis"},{"key":"2793_CR47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41380-022-01652-1","volume":"27","author":"GC Medeiros","year":"2022","unstructured":"Medeiros GC, Gould TD, Prueitt WL et al (2022) Blood-based biomarkers of antidepressant response to ketamine and esketamine: a systematic review and meta-analysis. Mol Psychiatry 2022 27:9. https:\/\/doi.org\/10.1038\/s41380-022-01652-1","journal-title":"Mol Psychiatry 2022"},{"key":"2793_CR48","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/J.NEULET.2013.08.051","volume":"554","author":"DK Miller","year":"2013","unstructured":"Miller DK, Oelrichs CE, Sage AS et al (2013) Repeated resveratrol treatment attenuates methamphetamine-induced hyperactivity and [3H]dopamine overflow in rodents. Neurosci Lett 554:53\u201358. https:\/\/doi.org\/10.1016\/J.NEULET.2013.08.051","journal-title":"Neurosci Lett"},{"key":"2793_CR49","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0160-5402(85)90021-X","volume":"13","author":"A Morinan","year":"1985","unstructured":"Morinan A, Garratt HM (1985) An improved fluorimetric assay for brain monoamine oxidase. J Pharmacol Methods 13:213\u2013223. https:\/\/doi.org\/10.1016\/0160-5402(85)90021-X","journal-title":"J Pharmacol Methods"},{"key":"2793_CR50","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/SCHBUL\/SBY024","volume":"44","author":"N M\u00fcller","year":"2018","unstructured":"M\u00fcller N (2018) Inflammation in Schizophrenia: pathogenetic aspects and therapeutic considerations. Schizophr Bull 44:973\u2013982. https:\/\/doi.org\/10.1093\/SCHBUL\/SBY024","journal-title":"Schizophr Bull"},{"key":"2793_CR51","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/S11064-022-03787-7\/FIGURES\/10","volume":"48","author":"HD Nguyen","year":"2023","unstructured":"Nguyen HD (2023) Resveratrol, Endocrine Disrupting Chemicals, neurodegenerative diseases and Depression: genes, transcription factors, microRNAs, and sponges involved. Neurochem Res 48:604\u2013624. https:\/\/doi.org\/10.1007\/S11064-022-03787-7\/FIGURES\/10","journal-title":"Neurochem Res"},{"key":"2793_CR52","doi-asserted-by":"publisher","first-page":"172547","DOI":"10.1016\/J.EJPHAR.2019.172547","volume":"860","author":"A Nowacka","year":"2019","unstructured":"Nowacka A, Borczyk M (2019) Ketamine applications beyond anesthesia \u2013 a literature review. Eur J Pharmacol 860:172547. https:\/\/doi.org\/10.1016\/J.EJPHAR.2019.172547","journal-title":"Eur J Pharmacol"},{"key":"2793_CR53","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1007\/S11064-016-1961-6\/FIGURES\/4","volume":"41","author":"LR Peroza","year":"2016","unstructured":"Peroza LR, Schaffer LF, De Freitas CM et al (2016) Alteration of cytokines levels in the striatum of rats: possible participation in Vacuous Chewing movements Induced by Antipsycotics. Neurochem Res 41:2481\u20132489. https:\/\/doi.org\/10.1007\/S11064-016-1961-6\/FIGURES\/4","journal-title":"Neurochem Res"},{"key":"2793_CR54","doi-asserted-by":"publisher","unstructured":"Pribish A, Wood N, Kalava A (2020) A review of Nonanesthetic uses of ketamine. https:\/\/doi.org\/10.1155\/2020\/5798285. Anesthesiol Res Pract 2020:","DOI":"10.1155\/2020\/5798285"},{"key":"2793_CR55","doi-asserted-by":"publisher","unstructured":"Prieur EAK, Jadavji NM (2019) Assessing spatial Working Memory using the spontaneous alternation Y-maze test in aged male mice. Bio Protoc 9. https:\/\/doi.org\/10.21769\/BIOPROTOC.3162","DOI":"10.21769\/BIOPROTOC.3162"},{"key":"2793_CR56","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S1734-1140(12)70879-4","volume":"64","author":"VS Rao","year":"2012","unstructured":"Rao VS, Carvalho AC, Trevisan MTS et al (2012) Mangiferin ameliorates 6-hydroxydopamineinduced cytotoxicity and oxidative stress in ketamine model of schizophrenia. Pharmacol Rep 64:848\u2013856. https:\/\/doi.org\/10.1016\/S1734-1140(12)70879-4","journal-title":"Pharmacol Rep"},{"issue":"10","key":"2793_CR57","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1038\/s41596-020-0382-9","volume":"15","author":"B Rein","year":"2020","unstructured":"Rein B, Ma K, Yan Z (2020) A standardized social preference protocol for measuring social deficits in mouse models of autism. Nat Protocols 2020 15(10):3464\u20133477. https:\/\/doi.org\/10.1038\/s41596-020-0382-9","journal-title":"Nat Protocols 2020"},{"issue":"12","key":"2793_CR58","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/S00210-020-01923-0","volume":"393","author":"JB Reinheimer","year":"2020","unstructured":"Reinheimer JB, Bressan GN, de Freitas CM et al (2020) Effects of CATECHIN on reserpine-induced vacuous chewing movements: behavioral and biochemical analysis. Naunyn-Schmiedeberg\u2019s Archives Pharmacol 2020 393(12):2439\u20132452. https:\/\/doi.org\/10.1007\/S00210-020-01923-0","journal-title":"Naunyn-Schmiedeberg\u2019s Archives Pharmacol 2020"},{"key":"2793_CR59","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/J.ARCMED.2020.01.010","volume":"51","author":"G Repossi","year":"2020","unstructured":"Repossi G, Das UN, Eynard AR (2020) Molecular basis of the Beneficial Actions of Resveratrol. Arch Med Res 51:105\u2013114. https:\/\/doi.org\/10.1016\/J.ARCMED.2020.01.010","journal-title":"Arch Med Res"},{"key":"2793_CR60","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/J.FCT.2009.03.010","volume":"47","author":"KKR Rocha","year":"2009","unstructured":"Rocha KKR, Souza GA, Ebaid GX et al (2009) Resveratrol toxicity: effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets. Food Chem Toxicol 47:1362\u20131367. https:\/\/doi.org\/10.1016\/J.FCT.2009.03.010","journal-title":"Food Chem Toxicol"},{"key":"2793_CR61","doi-asserted-by":"publisher","first-page":"173658","DOI":"10.1016\/J.PBB.2023.173658","volume":"233","author":"T Rodrigues","year":"2023","unstructured":"Rodrigues T, Bressan GN, Krum BN et al (2023) Influence of the dose of ketamine used on schizophrenia-like symptoms in mice: a correlation study with TH, GAD67, and PPAR-\u03b3. Pharmacol Biochem Behav 233:173658. https:\/\/doi.org\/10.1016\/J.PBB.2023.173658","journal-title":"Pharmacol Biochem Behav"},{"key":"2793_CR62","doi-asserted-by":"publisher","unstructured":"Salehi B, Mishra AP, Nigam M et al (2018) Resveratrol: A Double-Edged Sword in Health Benefits. Biomedicines 2018, Vol 6, Page 91 6:91. https:\/\/doi.org\/10.3390\/BIOMEDICINES6030091","DOI":"10.3390\/BIOMEDICINES6030091"},{"key":"2793_CR63","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1021\/ACSCHEMNEURO.0C00067\/SUPPL_FILE\/CN0C00067_SI_001.PDF","volume":"11","author":"A S\u00e1nchez-Melgar","year":"2020","unstructured":"S\u00e1nchez-Melgar A, Albasanz JL, Pall\u00e0s M, Mart\u00edn M (2020) Resveratrol Differently Modulates Group i metabotropic glutamate receptors depending on age in SAMP8 mice. ACS Chem Neurosci 11:1770\u20131780. https:\/\/doi.org\/10.1021\/ACSCHEMNEURO.0C00067\/SUPPL_FILE\/CN0C00067_SI_001.PDF","journal-title":"ACS Chem Neurosci"},{"key":"2793_CR64","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1007\/S11064-015-1811-Y\/FIGURES\/9","volume":"41","author":"LF Schaffer","year":"2016","unstructured":"Schaffer LF, de Freitas CM, Chiapinotto Ceretta AP et al (2016) Harpagophytum Procumbens Ethyl acetate fraction reduces Fluphenazine-Induced Vacuous chewing movements and oxidative stress in rat brain. Neurochem Res 41:1170\u20131184. https:\/\/doi.org\/10.1007\/S11064-015-1811-Y\/FIGURES\/9","journal-title":"Neurochem Res"},{"key":"2793_CR65","doi-asserted-by":"publisher","unstructured":"Shaito A, Posadino AM, Younes N et al (2020) Potential adverse effects of Resveratrol: A literature review. Int J Mol Sci 2020 21 Page 2084 21:2084. https:\/\/doi.org\/10.3390\/IJMS21062084","DOI":"10.3390\/IJMS21062084"},{"key":"2793_CR66","doi-asserted-by":"publisher","unstructured":"Shayganfard M (2020) Molecular and biological functions of resveratrol in psychiatric disorders: a review of recent evidence. Cell Bioscience 2020 10:1(10:1\u201314). https:\/\/doi.org\/10.1186\/S13578-020-00491-3","DOI":"10.1186\/S13578-020-00491-3"},{"key":"2793_CR67","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/J.NEULET.2013.02.050","volume":"542","author":"T Shuto","year":"2013","unstructured":"Shuto T, Kuroiwa M, Koga Y et al (2013) Acute effects of resveratrol to enhance cocaine-induced dopamine neurotransmission in the striatum. Neurosci Lett 542:107\u2013112. https:\/\/doi.org\/10.1016\/J.NEULET.2013.02.050","journal-title":"Neurosci Lett"},{"key":"2793_CR68","doi-asserted-by":"publisher","first-page":"112433","DOI":"10.1016\/J.FCT.2021.112433","volume":"155","author":"A Singh","year":"2021","unstructured":"Singh A, Yadawa AK, Chaturvedi S et al (2021) Mechanism for antiParkinsonian effect of resveratrol: involvement of transporters, synaptic proteins, dendrite arborization, biochemical alterations, ER stress and apoptosis. Food Chem Toxicol 155:112433. https:\/\/doi.org\/10.1016\/J.FCT.2021.112433","journal-title":"Food Chem Toxicol"},{"key":"2793_CR69","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/s0024-3205(01)01178-x","volume":"69","author":"R Soto-Otero","year":"2001","unstructured":"Soto-Otero R, M\u00e9ndez-\u00c1lvarez E, Hermida-Ameijeiras \u00c1 et al (2001) Inhibition of brain monoamine oxidase activity by the generation of hydroxyl radicals potential implications in relation to oxidative stress. Life Sci 69:879\u2013889. https:\/\/doi.org\/10.1016\/s0024-3205(01)01178-x","journal-title":"Life Sci"},{"key":"2793_CR70","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1017\/S1092852918001013","volume":"23","author":"SM Stahl","year":"2018","unstructured":"Stahl SM (2018) Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate. CNS Spectr 23:187\u2013191. https:\/\/doi.org\/10.1017\/S1092852918001013","journal-title":"CNS Spectr"},{"key":"2793_CR72","doi-asserted-by":"publisher","unstructured":"Tang X, Zhao Y, Zhou Z et al (2020) Resveratrol mitigates Sevoflurane-Induced neurotoxicity by the SIRT1-Dependent regulation of BDNF expression in developing mice. https:\/\/doi.org\/10.1155\/2020\/9018624. Oxid Med Cell Longev 2020:","DOI":"10.1155\/2020\/9018624"},{"key":"2793_CR73","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1002\/MED.21561","volume":"39","author":"RKP Tripathi","year":"2019","unstructured":"Tripathi RKP, Ayyannan SR (2019) Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: an overview and update. Med Res Rev 39:1603\u20131706. https:\/\/doi.org\/10.1002\/MED.21561","journal-title":"Med Res Rev"},{"key":"2793_CR74","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1111\/CNS.14276","volume":"29","author":"W Tu","year":"2023","unstructured":"Tu W, Song M, Fan X (2023) Does resveratrol improve cognition in humans? A scientometric study to an in-depth review. CNS Neurosci Ther 29:2413\u20132429. https:\/\/doi.org\/10.1111\/CNS.14276","journal-title":"CNS Neurosci Ther"},{"key":"2793_CR75","doi-asserted-by":"publisher","first-page":"4412","DOI":"10.1111\/BCP.15374","volume":"88","author":"JL Tully","year":"2022","unstructured":"Tully JL, Dahl\u00e9n AD, Haggarty CJ et al (2022) Ketamine treatment for refractory anxiety: a systematic review. Br J Clin Pharmacol 88:4412\u20134426. https:\/\/doi.org\/10.1111\/BCP.15374","journal-title":"Br J Clin Pharmacol"},{"key":"2793_CR76","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/S10571-007-9152-2\/FIGURES\/5","volume":"27","author":"LM Vieira De Almeida","year":"2007","unstructured":"Vieira De Almeida LM, Pi\u00f1eiro CC, Leite MC et al (2007) Resveratrol increases glutamate uptake, glutathione content, and S100B secretion in cortical astrocyte cultures. Cell Mol Neurobiol 27:661\u2013668. https:\/\/doi.org\/10.1007\/S10571-007-9152-2\/FIGURES\/5","journal-title":"Cell Mol Neurobiol"},{"key":"2793_CR77","doi-asserted-by":"publisher","unstructured":"Wang G, Zhu W (2016) Molecular docking for drug discovery and development: a widely used approach but far from perfect. Future Med Chem 8. https:\/\/doi.org\/10.4155\/FMC-2016-0143","DOI":"10.4155\/FMC-2016-0143"},{"key":"2793_CR78","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1080\/1028415X.2018.1461458","volume":"22","author":"YJ Wang","year":"2019","unstructured":"Wang YJ, Hsieh CP, Chan MH et al (2019) Distinct effects of resveratrol on seizures and hyperexcitability induced by NMDA and 4-aminopyridine. Nutr Neurosci 22:867\u2013876. https:\/\/doi.org\/10.1080\/1028415X.2018.1461458","journal-title":"Nutr Neurosci"},{"key":"2793_CR79","doi-asserted-by":"publisher","first-page":"1172091","DOI":"10.3389\/FNBEH.2023.1172091\/BIBTEX","volume":"17","author":"RM Wei","year":"2023","unstructured":"Wei RM, Zhang YM, Feng YZ et al (2023) Resveratrol ameliorates maternal separation-induced anxiety- and depression-like behaviors and reduces Sirt1-NF-kB signaling-mediated neuroinflammation. Front Behav Neurosci 17:1172091. https:\/\/doi.org\/10.3389\/FNBEH.2023.1172091\/BIBTEX","journal-title":"Front Behav Neurosci"},{"key":"2793_CR80","doi-asserted-by":"publisher","first-page":"212749","DOI":"10.3390\/IJMS21082749","volume":"21","author":"M Wici\u0144ski","year":"2020","unstructured":"Wici\u0144ski M, Domanowska A, W\u00f3dkiewicz E, Malinowski B (2020) Neuroprotective Properties of Resveratrol and its derivatives\u2014influence on potential mechanisms leading to the development of Alzheimer\u2019s Disease. Int J Mol Sci 2020 21:212749. https:\/\/doi.org\/10.3390\/IJMS21082749","journal-title":"Int J Mol Sci 2020"},{"key":"2793_CR81","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/J.JPSYCHIRES.2014.12.012","volume":"61","author":"K Xu","year":"2015","unstructured":"Xu K, Krystal JH, Ning Y et al (2015) Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia. J Psychiatr Res 61:64\u201372. https:\/\/doi.org\/10.1016\/J.JPSYCHIRES.2014.12.012","journal-title":"J Psychiatr Res"},{"key":"2793_CR82","doi-asserted-by":"publisher","unstructured":"Youdim MBH, Bakhle YS (2006) Monoamine oxidase: isoforms and inhibitors in Parkinson\u2019s disease and depressive illness. Br J Pharmacol 147. https:\/\/doi.org\/10.1038\/SJ.BJP.0706464","DOI":"10.1038\/SJ.BJP.0706464"},{"key":"2793_CR83","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/J.JPSYCHIRES.2012.10.018","volume":"47","author":"Y Yu","year":"2013","unstructured":"Yu Y, Wang R, Chen C et al (2013) Antidepressant-like effect of trans-resveratrol in chronic stress model: behavioral and neurochemical evidences. J Psychiatr Res 47:315\u2013322. https:\/\/doi.org\/10.1016\/J.JPSYCHIRES.2012.10.018","journal-title":"J Psychiatr Res"},{"key":"2793_CR84","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1080\/01616412.2021.1948749","volume":"43","author":"O Yunuso\u011flu","year":"2021","unstructured":"Yunuso\u011flu O (2021) Resveratrol impairs acquisition, reinstatement and precipitates extinction of alcohol-induced place preference in mice. Neurol Res 43:985\u2013994. https:\/\/doi.org\/10.1080\/01616412.2021.1948749","journal-title":"Neurol Res"},{"key":"2793_CR71","doi-asserted-by":"publisher","unstructured":"Zadeh Taheri Z, Esmaeilpour K, Aminzadeh A et al (2021) Resveratrol attenuates Learning, Memory, and Social Interaction impairments in rats exposed to Arsenic. Biomed Res Int 2021. https:\/\/doi.org\/10.1155\/2021\/9993873","DOI":"10.1155\/2021\/9993873"},{"key":"2793_CR85","doi-asserted-by":"publisher","unstructured":"Zhang LX, Li CX, Kakar MU et al (2021) Resveratrol (RV): a pharmacological review and call for further research. Biomed Pharmacother 143. https:\/\/doi.org\/10.1016\/J.BIOPHA.2021.112164","DOI":"10.1016\/J.BIOPHA.2021.112164"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-024-02793-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-024-02793-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-024-02793-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T20:23:18Z","timestamp":1724444598000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-024-02793-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":85,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["2793"],"URL":"https:\/\/doi.org\/10.1007\/s00702-024-02793-z","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,14]]},"assertion":[{"value":"13 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Committee approved the experimental protocol for Animal Care and Use of the Federal University of Santa Maria (CEUA\/UFSM) under number CEUA 4721190619.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}